- The share
- Press releases
- Financial calendar
- Financial reports
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- CODE OF CONDUCT
- Thank you
Conference call on Report on Operations
Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the report on operations 2020. The presentation will be held in English.
Time: Thursday, January 28 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
Phone numbers to the conference:
Sweden Toll-Free: 0200883685 PIN: 37331004#
Sweden Toll: +46 856642651 PIN: 37331004#
United Kingdom Toll-Free: 08003589473 PIN: 37331004#
United Kingdom Toll: +44 3333000804 PIN: 37331004#
United States Toll-Free: +18558570686 PIN: 37331004#
United States Toll: +1 6319131422 PIN: 37331004#
Conference name: XVIVO Perfusion Report on Operations 2020. Conferens ID: EV00119149
Participants from XVIVO Perfusion:
Dag Andersson, CEO
Kristoffer Nordström, CFO
The press release for XVIVO Perfusion’s report on operations 2020 will be released on January 28, 2020 at 7.30 a.m. (CET).
Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.
January 8, 2021
XVIVO Perfusion AB (publ)
For further information, please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-mail: firstname.lastname@example.org
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: email@example.com
XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden, one office in Groningen, the Netherlands and one office in Denver, USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.